Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market Report 2026

Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market Overview

• Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration market size has reached to $0.7 billion in 2025 • Expected to grow to $1.06 billion in 2030 at a compound annual growth rate (CAGR) of 8.7% • Growth Driver: Rise In Pancreatic Disorders Fueling The Growth Of The Market Due To Increasing Diabetes Prevalence And Cancer Incidence • Market Trend: Innovations In EUS Biopsy Needle Design To Improve Tissue Sampling And Diagnostic Accuracy In Gastrointestinal Procedures • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market?

Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) is a minimally invasive diagnostic procedure that combines endoscopic ultrasound (EUS) imaging with fine needle aspiration (FNA) to collect tissue or fluid samples from internal organs or structures. It is used to collect tissue or fluid samples from deep internal organs such as the pancreas, lymph nodes, or liver by inserting a thin needle through an ultrasound-equipped endoscope, allowing doctors to diagnose cancers, cysts, or other abnormalities with high accuracy and minimal invasiveness. The main types of endoscopic ultrasound (EUS)-guided fine needle aspiration are enteral endoscopic ultrasound needles and bronchial endoscopic ultrasound needles. Enteral endoscopic ultrasound needles are designed for use through the gastrointestinal tract to access and sample internal organs and structures adjacent to the esophagus, stomach, or intestines. It includes various product types, such as manual endoscopic ultrasound-guided fine needle aspiration (FNA) needles, powered endoscopic ultrasound-guided fine needle aspiration (FNA) needles, accessories for endoscopic ultrasound-guided fine needle aspiration (FNA) procedures, and sample collection devices, and it is used for various procedures such as endoscopic ultrasound-guided fine needle aspiration (FNA) for tumor diagnosis, endoscopic ultrasound-guided fine needle aspiration (FNA) for cystic lesions, endoscopic ultrasound-guided fine needle aspiration (FNA) for lymph node biopsies, and endoscopic ultrasound-guided fine needle aspiration (FNA) for solid organ biopsies. It finds applications in gastroenterology, oncology, pulmonology, and endocrinology, catering to diverse end users including hospitals, ambulatory surgical centers, specialty clinics, and others.

What Is The Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market Growth Forecast?

The endoscopic ultrasound (eus)-guided fine needle aspiration market size is expected to see strong growth in the next few years. It will grow to $1.06 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to technological advancement in powered eus-fna needles, rising prevalence of pancreatic and gastrointestinal cancers, expansion of gastroenterology and oncology clinics, growing demand for minimally invasive procedures, integration with advanced imaging and robotics. Major trends in the forecast period include rising adoption of minimally invasive diagnostic procedures, increasing use of eus-fna in oncology and gastroenterology, growth in powered and manual fine needle aspiration needles, expansion of specialty clinics and ambulatory surgical centers, focus on enhanced sample accuracy and reduced patient discomfort.

What Is The Driver Of The Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market?

The growing incidence of pancreatic disorders is expected to propel the growth of the endoscopic ultrasound (EUS)-guided fine needle aspiration market going forward. Pancreatic disorders refer to diseases and conditions that affect the pancreas, including inflammation, tumors, and functional impairments that impact digestion and hormone production. The incidence of pancreatic disorders is increasing due to the rising prevalence of diabetes, which places added stress on the pancreas and contributes to both inflammatory and functional pancreatic conditions. Endoscopic ultrasound (EUS)-guided fine needle aspiration is valuable in managing pancreatic disorders by enabling minimally invasive, accurate sampling of pancreatic lesions, aiding in the diagnosis of conditions such as cancer, cysts, and chronic pancreatitis. For instance, in February 2025, according to Cancer Australia, an Australia-based government agency, pancreatic cancer caused 3,687 deaths in Australia in 2022 (1,912 males and 1,775 females), which increased to 3,902 deaths in 2024 (2,027 males and 1,875 females). Therefore, the growing incidence of pancreatic disorders is driving the growth of the endoscopic ultrasound (EUS)-guided fine needle aspiration industry.

Key Players In The Global Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market

Major companies operating in the endoscopic ultrasound (eus)-guided fine needle aspiration market are Medtronic plc, Fujifilm Holdings Corporation, Becton Dickinson and Company, Boston Scientific Corporation, Olympus Corporation, Terumo Corporation, Steris plc, Cook Medical LLC, Canon Medical Systems Corporation, CONMED Corporation, Pentax Medical, Argon Medical Devices Inc., Fannin Limited, Zhejiang Soudon Medical Technology Co. Ltd., Micro-Tech Endoscopy USA Inc., CIVCO Medical Solutions, Medorah Meditek Pvt. Ltd., ACE Medical Devices Pvt. Ltd., ENDO-FLEX GmbH, Limaca Medical Ltd., Medi-Globe GmbH, ZKSK Medical Technology Co. Ltd.

Global Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market Trends and Insights

Major companies operating in the endoscopic ultrasound (EUS)-guided fine needle aspiration market are focusing on advancing needle technologies, such as endoscopic ultrasound fine biopsy needles, to enhance precision and tissue yield during procedures. Endoscopic ultrasound fine biopsy needles refer to specialized needles designed to obtain core tissue samples during EUS-guided procedures, allowing for more accurate histological diagnosis compared to conventional aspiration needles. For instance, in May 2024, Cook Medical, a US-based medical device company, launched the EchoTip ClearCore EUS Biopsy Needle, a next-generation device designed for precision biopsies of gastrointestinal lesions. This 22-gauge needle is used with an ultrasound endoscope for fine needle biopsies (FNB) of submucosal and extramural lesions, mediastinal masses, lymph nodes, and intraperitoneal masses near or within the gastrointestinal tract. It features a cobalt chromium Franseen tip for enhanced sharpness, enabling tissue puncture with minimal force and precise control, and a flexible, spring-coiled sheath that allows access to difficult anatomical locations.

What Are Latest Mergers And Acquisitions In The Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market?

In January 2024, Canon Medical Systems Corporation, a Japan-based medical equipment company, partnered with Olympus Corporation to develop and commercialize endoscopic ultrasound systems. This partnership aims to provide advanced endoscopic ultrasound systems that deliver high-quality diagnostic imaging, thereby enhancing diagnostic performance and supporting the early detection and minimally invasive treatment of diseases, initially in Japan and Europe with plans for global expansion. Olympus Corporation is a Japan-based manufacturer of optics and reprography products that offers a range of equipment and devices for endoscopic ultrasound (EUS)-guided fine needle aspiration (FNA).

What Defines the Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market?

The endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) market consists of sales of echogenic tip needles, real-time imaging probes, stylet systems, sheath stabilizers, and integrated ultrasound biopsy kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market Report 2026?

The endoscopic ultrasound (eus)-guided fine needle aspiration market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the endoscopic ultrasound (eus)-guided fine needle aspiration industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.